These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 17384671)
1. Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter. Brandes JC; Carraway H; Herman JG Oncogene; 2007 Sep; 26(42):6229-37. PubMed ID: 17384671 [TBL] [Abstract][Full Text] [Related]
2. The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase. Treilleux I; Chapot B; Goddard S; Pisani P; Angèle S; Hall J Histopathology; 2007 Jul; 51(1):63-9. PubMed ID: 17593081 [TBL] [Abstract][Full Text] [Related]
3. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer. Wang SH; Liu NH; Wang J; Bai H; Mao L Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105 [TBL] [Abstract][Full Text] [Related]
4. Contribution of mutations in ATM to breast cancer development in the Czech population. Soukupova J; Dundr P; Kleibl Z; Pohlreich P Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation. Bose S; Starczynski J; Chukwuma M; Baumforth K; Wei W; Morgan S; Byrd P; Ying J; Grundy R; Mann JR; Tao Q; Taylor AM; Murray PG; Stankovic T J Pathol; 2007 Nov; 213(3):329-36. PubMed ID: 17876757 [TBL] [Abstract][Full Text] [Related]
6. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas. Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875 [TBL] [Abstract][Full Text] [Related]
8. The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Vo QN; Kim WJ; Cvitanovic L; Boudreau DA; Ginzinger DG; Brown KD Oncogene; 2004 Dec; 23(58):9432-7. PubMed ID: 15516988 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors. Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119 [TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Kim WJ; Vo QN; Shrivastav M; Lataxes TA; Brown KD Oncogene; 2002 May; 21(24):3864-71. PubMed ID: 12032824 [TBL] [Abstract][Full Text] [Related]
13. PRIMEGENS-v2: genome-wide primer design for analyzing DNA methylation patterns of CpG islands. Srivastava GP; Guo J; Shi H; Xu D Bioinformatics; 2008 Sep; 24(17):1837-42. PubMed ID: 18579568 [TBL] [Abstract][Full Text] [Related]
14. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916 [TBL] [Abstract][Full Text] [Related]
15. Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation. Umetani N; de Maat MF; Sunami E; Hiramatsu S; Martinez S; Hoon DS Mol Cancer Res; 2006 May; 4(5):303-9. PubMed ID: 16687485 [TBL] [Abstract][Full Text] [Related]
16. MSP-HTPrimer: a high-throughput primer design tool to improve assay design for DNA methylation analysis in epigenetics. Pandey RV; Pulverer W; Kallmeyer R; Beikircher G; Pabinger S; Kriegner A; Weinhäusel A Clin Epigenetics; 2016; 8():101. PubMed ID: 27688817 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the porcine ATM gene: towards the generation of a novel non-murine animal model for Ataxia-Telangiectasia. Rogatcheva MB; Fritz KL; Rund LA; Pollock CB; Beever JE; Counter CM; Schook LB Gene; 2007 Dec; 405(1-2):27-35. PubMed ID: 17933474 [TBL] [Abstract][Full Text] [Related]
18. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328 [TBL] [Abstract][Full Text] [Related]
19. BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes. Tusnády GE; Simon I; Váradi A; Arányi T Nucleic Acids Res; 2005 Jan; 33(1):e9. PubMed ID: 15653630 [TBL] [Abstract][Full Text] [Related]
20. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers. Kontorovich T; Cohen Y; Nir U; Friedman E Breast Cancer Res Treat; 2009 Jul; 116(1):195-200. PubMed ID: 18642075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]